Home/Research
Research 2017-06-05T03:35:55+00:00

Research and Related Publications

The corporate culture of Farabloc has been committed to science and the highest standards of research on the effects of the absence of electromagnetic fields (EMF).

We are pleased to note studies on the absence of EMF, using applications from Farabloc Development Corporation, are published and found on PubMed and other clinical information.

Search for “Farabloc” in NIH

2015August

Improving Functional Outcomes for Vascular Amputees Through Use of Mirror Therapy and Elimination of the Effects of Electromagnetic Fields.

PubMed-LogoThis study aimed to ascertain the effectiveness of using a combined treatment protocol of eliminating electromagnetic fields by use of the Farabloc technology and the exercise program of Mirror Therapy. The main hypothesis was that the combined treatment protocol would have a more significant effect than either treatment in isolation. Decreasing edema and the discomfort due to phantom limb pain would improve the functional activities and quality of life of vascular amputees with lower extremity amputations. This was found to be true.
Occupational Therapy Health Care, 2016

PMID: 26295593

Read abstract  >>

Excerpt: ”Farabloc Technology” >>

2013April

Aluminium foil for the prevention of post-amputation pain: a randomised, double- blinded, placebo-controlled, crossover trial

Phantom limb pain (PLP) is a painful sensation perceived in the missing limb after amputation. The underlying pathophysiology remains unclear. Until recently, only opioid analgesics have been proven to be effective in prospective studies. Anecdotally, patients with PLP employ self-help measures, sometimes including ‘wrapping up’ or rubbing their stump with aluminium foil for relief. Our hypothesis is that wrapping an amputation stump with aluminium foil perioperatively will prevent PLP in the postoperative period.

Read Article >>

2012October

Poster Presentations at the Annual Convention of the American Congress of Rehabilitation Medicine 2012

Farabloc related presentations

1) Improving Functional Outcomes for Vascular Amputees Through Innovative Technology
2) Innovative Technology to Improve Functional Outcomes for Vascular Amputees: Case Studies
3) The Absence of Electromagnetic Fields and Mirror Therapy to Reduce Vascular Amputee Phantom Limb PainVidant Hospital, Greenville, North Carolina, East Carolina University

Read More >>

2012June

The effectiveness of Farabloc technology with Mirror Therapy in reducing phantom limb pain in individuals with a unilateral lower extremity vascular amputation

by Houston, Helen, M.S., EAST CAROLINA UNIVERSITY, 2012, 109 pages; 1510513

The objective of this study was to investigate the effectiveness of combining two interventions, Farabloc technology to eliminate electromagnetic fields and Mirror Therapy to assist in the sensory cortex reorganization, to decrease or eliminate phantom limb pain in vascular amputees.

Read article >>

2010April

Amputees experiencing Phantom Limb Pain – The Farabloc Stump Sock

Systematic Reviews

Two systematic reviews found evidence to support Farabloc as an effective treatment for management of PLP (Halbert et al., 2002; Stanndard,Kalso,&Ballantyne,2010).

  • The 2002 review on the optimal management of acute and chronic PLP, documented that Farabloc research was only one of three studies to score the maximumof five points for a quality assessment. For late PLP (greater than 2‐week post operatively), this review agreed that there is evidence suggesting that Farabloc is an effective treatment.
    (The Clinical Journal of Pain, 18:84–92 © 2002 Lippincott Williams & Wilkins, Inc., Philadelphia. ”Evidence for the Optimal Management of Acute and Chronic Phantom Pain: A Systematic Review”(Halbert et al.2002 PMID: 1188277).
  • The findings were affirmed in the second review, listing Farabloc as an intervention supported by evidence for the management of PLP (Stannard et al., 2010).
    (Nikolajsen, L. (2010) Phantom Limb Pain, in Evidence-Based Chronic Pain Management (eds C. F. Stannard, E. Kalso and J. Ballantyne), John Wiley & Sons, Ltd., West Sussex, UK.
    doi: 10.1002/9781444314380.ch19).
2007January

Efficacy of Farabloc as an analgesic in primary fibromyalgia

PubMed-LogoAn article in the respected British peer reviewed journal Clinical Rheumatology, published in January, 2007, by Dr. G.L. Bach and Dr. D.B. Clement.

The goal of our study was to determine the efficacy of Farabloc, an electromagnetic shielding fabric compared to placebo fabric when worn as a nightgown, as an analgesic in patients hospitalized with fibromyalgia. In a rheumatologic and rehabilitation hospital, we performed a phase 1, single-blind study of patients using Farabloc (F) or placebo (P) gowns for 8 h per night during the 20-day hospitalization and a phase 2, single-blind crossover study of patients using both F and P gowns randomly and alternatively switching after 10 of 21 days hospitalization.

PMID: 17216399

Read abstract >>

PDF file >>

2002March

Evidence for the optimal management of acute and chronic phantom pain: a systematic review.

PubMed-Logo

Clin J Pain. Philadelphia, PA 2002 March

The objective was to examine the evidence to determine the optimal management of phantom limb pain in the preoperative and postoperative phase of amputations.

Trials were identified by a systematic search of MEDLINE, review articles, and references of relevant trials from the period 1966-1999, including only English-language articles. Included trials involved a control group, any intervention, and reported phantom pain as an outcome.

PMID: 11882771

Read abstract >>

2000January

The efficacy of Farabloc, an electromagnetic shield, in attenuating delayed-onset muscle soreness

Clinical Journal of Sports Medicine, Philadelphia, PA

By Jian Zhang, M.Sc. Dr. Doug Clement and Dr. Jack Taunton, a study first published in the Clinical Journal of Sports Medicine, Philadelphia, PA in 2000

Two studies have shown that Farabloc reduces pain in human subjects who suffer from phantom limb pain or delayed onset muscle soreness, but the mechanism is unknown.

PMID: 10695845

Read abstract >>

PubMed-LogoClinical Journal of Sports Medicine, Philadelphia, PA (PubMed – indexed for MEDLINE) read more >>